Alvogen’s Lotus Picks Up Darbepoetin Alfa Rights In Asia

Biosimilar Agreement Covers Taiwan And Key Asian Markets

 
• By Dean Rudge
  
Asia - Pacific
The combined size of Lotus’ markets of interest is roughly US$30m • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business